Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Sharon Mates, PhD.$7.6B
Market Cap • 24/04/20242012
(há 12 anos)
2013
(11 years ago)
NASDAQ
Listagem
New York
Sede • New York561
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ITCISó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.